Who Owns Axsome Therapeutics Stock?
NASDAQ: AXSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 77.71%
- Held by insiders
- 15.02%
- Institutional holders
- 622
- Institutions 77.7%
- Insiders 15.0%
- Public and other 7.3%
Who owns Axsome Therapeutics stock?
Institutional investors own about 77.7% of Axsome Therapeutics's shares, spread across 622 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 15.02% of AXSM.
The largest institutional holders are Blackrock Inc. (6.56%), Vanguard Capital Management LLC (3.82%) and Vanguard Portfolio Management LLC (3.75%). Together, the top 10 institutions control 29.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AXSM positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AXSM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.45M | 6.56% | +11.2% |
| Vanguard Capital Management LLC | 2.01M | 3.82% | +2.1% |
| Vanguard Portfolio Management LLC | 1.97M | 3.75% | -0.6% |
| Invesco Ltd. | 1.93M | 3.67% | +15.5% |
| FMR, LLC | 1.44M | 2.75% | -6.2% |
| Two Sigma Investments, LP | 1.11M | 2.11% | +65.9% |
| Geode Capital Management, LLC | 1.01M | 1.92% | +4.5% |
| UBS Group AG | 849.77K | 1.62% | +459.4% |
| State Street Corporation | 823.33K | 1.57% | +4.8% |
| Deep Track Capital, Lp | 800.00K | 1.52% | +14.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AXSM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.39M | 2.64% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.00M | 1.91% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 578.23K | 1.10% |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 535.27K | 1.02% |
| Vanguard Explorer Fund | 531.00K | 1.01% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 495.76K | 0.94% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 387.24K | 0.74% |
| iShares Trust-iShares Biotechnology ETF | 343.59K | 0.65% |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 300.00K | 0.57% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 278.08K | 0.53% |
Frequently asked questions
Who is the largest shareholder of Axsome Therapeutics?
Blackrock Inc. is the largest institutional shareholder of AXSM, owning 6.56% of shares outstanding (3.45M shares) as of its latest 13F filing.
What percentage of Axsome Therapeutics is owned by institutions?
Institutions own about 77.7% of AXSM shares and 91.4% of the public float.
How much of Axsome Therapeutics do insiders own?
Insiders, such as officers and directors, own about 15.02% of AXSM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.